The study by Bekaert et al. demonstrated low VAT chemerin expression and high serum chemerin in obese patients with diagnosed NAFLD as compared to controls but its association with hepatic histopathologic grading is still not clear [16]. The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatotic liver disease.